Sex differences in the characteristics of stimulant offenders with a history of substance use disorder treatment.
inmates
methamphetamine
sex differences
substance use
treatment needs
Journal
Neuropsychopharmacology reports
ISSN: 2574-173X
Titre abrégé: Neuropsychopharmacol Rep
Pays: United States
ID NLM: 101719700
Informations de publication
Date de publication:
20 Jun 2023
20 Jun 2023
Historique:
revised:
16
05
2023
received:
19
01
2023
accepted:
24
05
2023
medline:
21
6
2023
pubmed:
21
6
2023
entrez:
21
6
2023
Statut:
aheadofprint
Résumé
We analyzed the results of a nationwide questionnaire administered to 699 stimulant offenders and examined sex differences in the association between various psychosocial problems and treatment history for substance use disorder. Based on their attributes, we predominantly evaluated the treatment and support provided to women with substance use disorder. The rates of childhood (before the age of 18) traumatic experiences (physical, psychological, and sexual abuse and neglect) and lifetime intimate partner violence were significantly higher in women than in men. The history of treatment for substance use disorder was also significantly higher in women than in men, at 15.8% for men and 42.4% for women [χ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Division of Research, National Center for Addiction Services Administration
ID : 2023-01
Informations de copyright
© 2023 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.
Références
Vearrier D, Greenberg MI, Miller SN, Okaneku JT, Haggerty DA. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Dis Mon. 2012;58(2):38-89.
Research and Training Institute, Ministry of Justice. (Edit) White Paper on Crime 2020 - Drug Offenses. 2020, p 50. (in Japanese).
Ministry of Justice. (edit) White paper on recidivism prevention. 2019 Tokyo: Nikkei Printing Inc. 2020, p 184. (in Japanese).
Kamoshita M, Takahashi M, Fujino K. Research on attributes of stimulant use offenders. Bull Chuo Res Cent. 2006;16:1-56. (in Japanese).
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
Webster JM, Rosen PJ, Krietemeyer J, Mateyoke-Scrivner A, Staton-Tindall M, Leukefeld C. Gender, mental health, and treatment motivation in a drug court setting. J Psychoactive Drugs. 2006;38(4):441-8.
Yatsugi S, Fujita K, Kashima S, Eboshida A. Drug dependence treatment awareness among Japanese female stimulant drug offenders. Int J Environ Res Public Health. 2016;13(11):1127.
Skinner HA, Goldberg AE. Evidence for a drug dependence syndrome among narcotic users. Br J Addict. 1986;81(4):479-84.
Shimane T, Imamura A, Ikeda K, Yamamoto M, Tsuji M, Nagayo Y, et al. Reliability and validity of the Japanese version of the DAST-20 (in Japanese). Nihon Arukoru Yakubutsu Igakkai Zasshi. 2015;50(6):310-24.
Matsumoto T. A treatment for drug dependence not requiring specialists: a treatment program based on a workbook, the “SMARPP.”. Seishin Shinkeigaku Zasshi. 2015;117(8):655-62. Japanese.
Obert JL, McCann MJ, Marinelli-Casey P, et al. The matrix model of outpatient stimulant abuse treatment: history and description. J Psychoactive Drugs. 2000;32(2):157-64.
Tanibuchi Y, Matsumoto T, Imamura F, et al. Efficacy of the Serigaya methamphetamine relapse prevention program (SMARPP): for patients with drug use disorder: a study on factors influencing 1-year follow-up outcomes. Nihon Arukoru Yakubutsu Igakkai Zasshi. 2016;51(1):38-54. Japanese.
Randall CL, Roberts JS, Del Boca FK, Carroll KM, Connors GJ, Mattson ME. Telescoping of landmark events associated with drinking: a gender comparison. J Stud Alcohol. 1999;60(2):252-60.
Afifi TO, Henriksen CA, Asmundson GJG, Sareen J. Childhood maltreatment and substance use disorders among men and women in a nationally representative sample. Can J Psychiatry. 2012a;57(11):677-86.
Afifi TO, Mota NP, Dasiewicz P, MacMillan HL, Sareen J. Physical punishment and mental disorders: results from a nationally representative US sample. Pediatrics. 2012b;130(2):184-92.
Afifi TO, Sareen J, Fortier J, et al. Child maltreatment and eating disorders among men and women in adulthood: results from a nationally representative United States sample. Int J Eat Disord. 2017;50(11):1281-96.
Greenfield SF, Back SE, Lawson K, Brady KT. Substance abuse in women. Psychiatr Clin North Am. 2010;33(2):339-55.
Piran N, Robinson S. The association between disordered eating and substance use and abuse in women: a community-based investigation. Women Health. 2006;44(1):1-20.
Jones MS, Peck BM, Sharp SF, McLeod DA. Childhood adversity and intimate partner violence in adulthood: the mediating influence of PTSD in a sample of women prisoners. J Interpers Violence. 2019;36:NP8590-614.
Cohen LR, Greenfield SF, Gordon S, Killeen T, Jiang H, Zhang Y, et al. Survey of eating disorder symptoms among women in treatment for substance abuse. Am J Addict. 2010;19(3):245-51.
Robinson LD, Kelly PJ, Deane FP, Reis SL. Exploring the relationships between eating disorders and mental health in women attending residential substance use treatment. J Dual Diagn. 2019;15(4):270-80.
Rockville, (MD): Substance Abuse and Mental Health Services Administration. 2009. Substance abuse treatment: addressing the specific needs of women treatment improvement protocol (TIP) series, No 51, p 4-6.
Najavits LM. Seeking safety: a treatment manual for PTSD and substance abuse. New York: Guilford Press; 2001.
Gordon SM, Johnson JA, Greenfield SF, Cohen L, Killeen T, Roman PM. Assessment and treatment of co-occurring eating disorders in publicly funded addiction treatment programs. Psychiatr Serv. 2008;59(9):1056-9.
Lindsay AR, Warren CS, Velasquez SC, Lu M. A gender-specific approach to improving substance abuse treatment for women: the healthy steps to freedom program. J Subst Abuse Treat. 2012;43(1):61-9.
Peters RH, Strozier AL, Murrin MR, Kearns WD. Treatment of substance-abusing jail inmates. Examination of gender differences. J Subst Abuse Treat. 1997;14(4):339-49.
Lewis C. Treating incarcerated women: gender matters. Psychiatr Clin North Am. 2006;29(3):773-89.
Lynch SM, Dehart DD, Belknap JE, et al. A multisite study of the prevalence of serious mental illness, PTSD, and substance use disorders of women in jail. Psychiatr Serv. 2014;65(5):670-4.
Karlsson ME, Zielinski MJ. Sexual victimization and mental illness prevalence rates among incarcerated women: a literature review. Trauma Violence Abuse. 2020;21(2):326-49. https://doi.org/10.1177/1524838018767933
Grella CE, Greenwell L. Treatment needs and completion of community-based aftercare among substance-abusing women offenders. Womens Health Issues. 2007;17(4):244-55.
Salina DD, Figge C, Ram D, Jason LA. Rates of traumatization and psychopathology in criminal justice-involved women. J Trauma Dissociation. 2017;18(2):174-88.
Marotta PL. Childhood adversities and substance misuse among the incarcerated: implications for treatment and practice in correctional settings. Subst Use Misuse. 2017;52(6):717-33.
Cohen JB, Greenberg R, Uri J, Halpin M, Zweben JE. Women with methamphetamine dependence: research on etiology and treatment. J Psychoactive Drugs. 2007;Suppl(4):347-51.